Spelling suggestions: "subject:"BIO/19 microbiologia"" "subject:"BIO/19 microbiologica""
1 |
Study of the genes involved in Naphthenic acids (NAs) degradation by Rhodococcus spp.Presentato, Alessandro <1985> January 1900 (has links)
Naphthenic acids (NAs) are an important group of organic pollutants mainly found in hydrocarbon deposits. Although these compounds are toxic, recalcitrant, and persistent in the environment, we are just learning the diversity of microbial communities involved in NAs- degradation and the mechanisms by which NAs are biodegraded. Studies have shown that naphthenic acids are susceptible to biodegradation, which decreases their concentration and reduces toxicity. Nevertheless, little is still known about their biodegradability. The present PhD Thesis’s work is aimed to study the biodegradation of simple model NAs using bacteria strains belonging to the Rhodococcus genus. In particular, Rh. sp. BCP1 and Rh. opacus R7 were able to utilize NAs such as cyclohexane carboxylic acid and cyclopentane carboxylic acid as the sole carbon and energy sources, even at concentrations up to 1000 mg/L. The presence of either substituents or longer carboxylic acid chains attached to the cyclohexane ring negatively affected the growth by pure bacterial cultures. Moreover, BCP1 and R7 cells incubated in the presence of CHCA or CPCA show a general increase of saturated and methyl-substituted fatty acids in their membrane, while the cis-mono-unsaturated ones decrease, as compared to glucose-grown cells. The observed lipid molecules modification during the growth in the presence of NAs is suggested as a possible mechanism to decrease the fluidity of the cell membrane to counteract NAs toxicity. In order to further evaluate this toxic effect on cell features, the morphological changes of BCP1 and R7 cells were also assessed through Transmission Electron Microscopy (TEM), revealing interesting ultrastructural changes. The induction of putative genes, and the construction of a random transposon mutagenesis library were also carried out to reveal the mechanisms by which these Rhodococcus strains can degrade toxic compounds such as NAs.
|
2 |
Physiological characterization of Pseudomonas pseudoalcaligenes KF707, biofilm and environmental stress responseTremaroli, Valentina <1978> 29 May 2007 (has links)
No description available.
|
3 |
Interazioni tra le glicoproteine D, B, H ed L critiche per la fusione indotta dal virus Herpes simplexForghieri, Cristina <1975> 03 July 2008 (has links)
Four glycoproteins (gD, gB, gH, and gL) are required for herpes simplex virus (HSV) entry into the cell and for cell-cell fusion in transfected cells. gD serves as the receptor-binding glycoprotein and as the trigger of fusion; the other three glycoproteins execute fusion between the viral envelope and the plasma or endocytic membranes. Little is known on the interaction of gD with gB, gH, and gL. Here, the interactions between herpes simplex virus gD and its nectin1 receptor or between gD, gB, and gH were analyzed by complementation of the N and C portions of split enhanced green fluorescent protein (EGFP) fused to the glycoproteins. Split EGFP complementation was detected between proteins designated gDN + gHC, gDN + gBC, and gHN + gBC + wtgD, both in cells transfected with two or tree glycoproteins and in cells transfected with the four glycoproteins, commited to form syncytia. The in situ assay provides evidence that gD interacts with gH and gB independently one of the other. We further document the interaction between gH and gB.
To elucidate which portions of the glycoproteins interact with each other we generated mutants of gD and gB. gD triggers fusion through a specialised domain, named pro-fusion domain (PFD), located C-terminally in the ectodomain. Here, we show that PFD is made of subdomains 1 and 2 (amino acids 260–285 and 285–310) and that each one partially contributed to herpes simplex virus infectivity. Chimeric gB molecules composed of HSV and human herpesvirus 8 (HHV8) sequences failed to reach the cell surface and to complement a gB defective virus. By means of pull down experiments we analyzed the interactions of HSV-HHV8 gB chimeras with gH or gD fused to the strep-tag. The gB sequence between aa residues 219-360 was identified as putative region of interaction with gH or critical to the interaction.
|
4 |
Molecular basis oh herpes simplex virus entry into the cell and retargeting of the viral tropism for the design of oncolytic herpesvirusesCerretani, Arianna <1980> 03 July 2008 (has links)
Herpes simplex virus 1 (HSV-1) infects oral epitelial cells, then spreads to the nerve endings and estabilishes latency in sensory ganglia, from where it may, or may not reactivate. Diseases caused by virus reactivation include mild diseases such as muco-cutaneous lesions, and more severe, and even life-threatening encephalitis, or systemic infections affecting diverse organs.
Herpes simplex virus represents the most comprehensive example of virus receptor interaction in Herpesviridae family, and the prototype virus encoding multipartite entry genes. In fact, it encodes 11-12 glycoproteins and a number of additional membrane proteins: five of these proteins play key roles in virus entry into subsceptible cells. Thus, glycoprotein B (gB) and glycoprotein C (gC) interact with heparan sulfate proteoglycan to enable initial attachment to cell surfaces. In the next step, in the entry cascade, gD binds a specific surface receptor such as nectin1 or HVEM. The interaction of glycoprotein D with the receptor alters the conformation of gD to enable the activation of gB, glycoprotein H, and glycoprotein L, a trio of glycoproteins that execute the fusion of the viral envelope with the plasma membrane.
In this thesis, I described two distinct projects:
I. The retargeting of viral tropism for the design of oncolytic Herpesviruses:
• capable of infecting cells through the human epitelial growth factor receptor 2 (HER2), overexpressed in highly malignant mammary and ovarian tumors and correlates with a poor prognosis;
• detargeted from its natural receptors, HVEM and nectin1.
To this end, we inserted a ligand to HER2 in gD. Because HER2 has no natural ligand, the selected ligand was a single chain antibody (scFv) derived from MAb4D5 (monoclonal antibody to HER2), herein designated scHER2.
All recombinant viruses were targeted to HER2 receptor, but only two viruses (R-LM113 and R-LM249) were completely detargeted from HVEM and nectin1.
To engineer R-LM113, we removed a large portion at the N-terminus of gD (from aa 6 to aa 38) and inserted scHER2 sequence plus 9-aa serine-glycine flexible linker at position 39. On the other hand, to engineer R-LM249, we replaced the Ig-folded core of gD (from aa 61 to aa 218) with scHER2 flanked by Ser-Gly linkers.
In summary, these results provide evidence that:
i. gD can tolerate an insert almost as big as gD itself;
ii. the Ig-like domain of gD can be removed;
iii. the large portion at the N-terminus of gD (from aa 6 to aa 38) can be removed without loss of key function;
iv. R-LM113 and R-LM249 recombinants are ready to be assayed in animal models of mammary and ovary tumour. This finding and the avaibility of a large number of scFv greatly increase the collection of potential receptors to which HSV can be redirected.
II. The production and purification of recombinant truncated form of the heterodimer gHgL.
We cloned a stable insect cell line expressing a soluble form of gH in complex with gL under the control of a metalloprotein inducible promoter and purified the heterodimer by means of ONE-STrEP-tag system by IBA.
With respect to biological function, the purified heterodimer is capable:
• of reacting to antibodies that recognize conformation dependent epitopes and neutralize virion infectivity;
• of binding a variety cells at cell surface.
No doubt, the availability of biological active purified gHgL heterodimer, in sufficient quantities, will speed up the efforts to solve its crystal structure and makes it feasible to identify more clearly whether gHgL has a cellular partner, and what is the role of this interaction on virus entry.
|
5 |
Interazioni tra Glicoproteine che mediano la penetrazione del Virus Herpes Simplex nella cellula e disegno razionale di Peptidi InibitoriAmasio, Michele <1979> 16 April 2009 (has links)
Herpes simplex virus entry into cells requires a multipartite fusion apparatus made of gD, gB and heterodimer gH/gL. gD serves as receptor-binding glycoprotein and trigger of fusion; its ectodomain is organized in a N-terminal domain carrying the receptor-binding sites, and a C-terminal domain carrying the profusion domain, required for fusion but not receptor-binding. gB and gH/gL execute fusion. To understand how the four glycoproteins cross-talk to each other we searched for biochemical defined complexes in infected and transfected cells, and in virions.
We report that gD formed complexes with gB in absence of gH/gL, and with gH/gL in absence of gB. Complexes with similar composition were formed in infected and transfected cells. They were also present in virions prior to entry, and did not increase at virus fusion with cell. A panel of gD mutants enabled the preliminary location of part of the binding site in gD to gB to the aa 240-260 portion and downstream, with T306P307 as critical residues, and of the binding site to gH/gL at aa 260-310 portion, with P291P292 as critical residues. The results indicate that gD carries composite independent binding sites for gB and gH/gL, both of which partly located in the profusion domain.
The second part of the project dealt with rational design of peptides inhibiting virus entry has been performed. Considering gB and gD, the crystal structure is known, so we designed peptides that dock in the structure or prevent the adoption of the final conformation of target molecule. Considering the other glycoproteins, of which the structure is not known, peptide libraries were analyzed. Among several peptides, some were identified as active, designed on glycoprotein B. Two of them were further analyzed. We identified peptide residues fundamental for the inhibiting activity, suggesting a possible mechanism of action. Furthermore, changing the flexibility of peptides, an increased activity was observed,with an EC50 under 10μM. New approaches will try to demonstrate the direct interaction between these peptides and the target glycoprotein B.
|
6 |
Autoinduzione dell'espressione genica per la produzione di proteine ricombinanti nelle fermentazioni industrialiNocadello, Salvatore <1981> 29 May 2009 (has links)
No description available.
|
7 |
Produzione di proteine ricombinanti in terreni privi di antibioticoBlasiotti, Alessandra <1981> 29 May 2009 (has links)
No description available.
|
8 |
Monooxygenases involved in the n-alkanes metabolism by Rhodococcus sp. BCP1: molecular characterization and expression of alkB gene / Monossigenasi coinvolte nel metabolismo di n-alcani in Rhodococcus sp. BCP1: caratterizzazione molecolare e espressione del gene alkBCappelletti, Martina <1981> 23 April 2010 (has links)
Bioremediation implies the use of living organisms, primarily microorganisms, to convert environmental contaminants into less toxic forms. The impact of the consequences of hydrocarbon release in the environment maintain a high research interest in the study of microbial metabolisms associated with the biodegradation of aromatic and aliphatic hydrocarbons but also in the analysis of microbial enzymes that can convert petroleum substrates to value-added products.
The studies described in this Thesis fall within the research field that directs the efforts into identifying gene/proteins involved in the catabolism of n-alkanes and into studying the regulatory mechanisms leading to their oxidation. In particular the studies were aimed at investigating the molecular aspects of the ability of Rhodococcus sp. BCP1 to grow on aliphatic hydrocarbons as sole carbon and energy sources.
We studied the ability of Rhodococcus sp. BCP1 to grow on gaseous (C2-C4), liquid (C5-C16) and solid (C17-C28) n-alkanes that resulted to be biochemically correlated with the activity of one or more monooxygenases. In order to identify the alkane monooxygenase that is involved in the n-alkanes degradation pathway in Rhodococcus sp. BCP1, PCR-based methodology was applied by using degenerate primers targeting AlkB monooxygenase family members. As result, a chromosomal region, including the alkB gene cluster, was cloned from Rhodococcus sp. BCP1 genome. We characterized the products of this alkB gene cluster and the products of the orfs included in the flanking regions by comparative analysis with the homologues in the database. alkB gene expression studies were carried out by RT-PCR and by the construction of a promoter probe vector containing the lacZ gene downstream of the alkB promoter. B-galactosidase assays revealed the alkB promoter activity induced by n-alkanes and by n-alkanes metabolic products. Furthermore, the transcriptional start of alkB gene was determined by primer extension procedure.
A proteomic approach was subsequently applied to compare the protein patterns expressed by BCP1 growing on n-butane, n-hexane, n-hexadecane or n-eicosane with the protein pattern expressed by BCP1 growing on succinate. The accumulation of enzymes specifically induced on n-alkanes was determined. These enzymes were identified by tandem mass spectrometry (LC/MS/MS).
Finally, a prm gene, homologue to the gene family coding for soluble di-iron monooxygenases (SDIMOs), has been isolated from Rhodococcus sp. BCP1 genome. This gene product could be involved in the degradation of gaseous n-alkanes in this Rhodococcus strain.
The versatility in utilizing hydrocarbons and the discovery of new remarkable metabolic activities outline the potential applications of this microorganism in environmental and industrial biotechnologies.
|
9 |
Molecular and functional characterization of the chemotactic genes in the PCBs-degrader Pseudomonas pseudoalcaligenes KF707 / Caratterizazione molecolare e funzionale dei geni per la chemiotassi nel batterio degradatore di PCBs, Pseudomonas pseudoalcaligenes KF707Triscari Barberi, Tania <1985> 22 April 2013 (has links)
Although bacteria represent the simplest form of life on Earth, they have a great impact on all living beings. For example the degrader bacterium Pseudomonas pseudoalcaligenes KF707 is used in bioremediation procedures for the recovery of polluted sites. Indeed, KF707 strain is know for its ability to degrade biphenyl and polychlorinated biphenyls - to which is chemotactically attracted - and to tolerate the oxydative stress due to toxic metal oxyanions such as tellurite and selenite. Moreover, in bioremediation processes, target compounds can be easily accessible to KF707 through biofilm formation. All these considerations suggest that KF707 is such a unique microorganism and this Thesis work has been focused on determining the molecular nature of some of the peculiar physiological traits of this strain. The genome project provided a large set of informations: putative genes involved in the degradation of aromatic and toxic compounds and associated to stress response were identified. Notably, multiple chemotactic operons and cheA genes were also found. Deleted mutants in the cheA genes were constructed and their role in motility, chemotaxis and biofilm formation were assessed and compared to those previously attributed to a cheA1 gene in a KF707 mutant constructed by a mini-Tn5 transposon insertion and which was impaired in motility and biofilm development. The results of this present Thesis work, taken together, were interpreted to suggest that in Pseudomonas pseudoalcaligenes KF707 strain, multiple factors are involved in these networks and they might play different roles depending on the environmental conditions. The ability of KF707 strain to produce signal molecules possibly involved in cell-to-cell communication, was also investigated: lack of a lux-like QS system - which is conversely widely present in Gram negative bacteria – keeps open the question about the actual molecular nature of KF707 quorum sensing mechanism. / Sebbene i batteri rappresentino delle forme di vita semplici, essi hanno un grande impatto sulla vita di tutti gli organismi viventi. Batteri come Pseudomomas pseudoalcaligenes KF707, vengono usati per il biorisanamento di aree inquinate. Infatti KF707 ha la capacità di degradare composti tossici quali i bifenili e i poli-cloro-bifenili (ai quali risulta chemotatticamente attratto) ed è capace di mettere in atto meccanismi di difesa allo stress ossidativo procurato da ioni metallici tossici. Inoltre ha anche la capacità di aderire a superfici solide e di crescere come biofilm. Tutte queste caratteristiche fanno di KF707 un microrganismo singolare e pertanto nel presente lavoro di Tesi, sono mostrati i risultati relativi alla caratterizzarione molecolare di alcuni tratti fisiologici tipici del microrganismo. I dati derivanti dall’analisi del genoma hanno fornito informazioni riguardo la presenza di geni codificanti enzimi coinvolti nella degradazione di composti aromatici, geni coinvoli nella risposta allo stress ossidativo ed in particolare la presenza di cluster chemotattici multipli e di tre geni cheA. Mutanti deleti nei nuovi geni cheA (cheA2 e cheA3) sono stati costruiti, con lo scopo di confrontare il loro ruolo nella risposta chemiotattica e nella formazione di biofilm con quello del gene cheA1 che era stato caratterizzato in un mutante privo di motilità e di capacita di sviluppare un biofilm maturo. I risultati suggeriscono che in KF707 il network potrebbe essere molto complesso in quanto i vari componenti di diverse pathways potrebbero interagire e anche essere espressi in diverse condizioni ambientali.
In più è stata valutata anche la capacità, da parte di KF707, di produrre molecole segnale coinvolte nei processi di comunicazione cellulare via quourum sensing e i risultati hanno mostrato che il ceppo non possiede un sistema lux-like tipico dei Gram negativi, aprendo nuove strade da esplorare per la ricerca di un circuito quorum sensing-like in KF707.
|
10 |
Costruzione di chimere molecolari dell'enzima Integrasi di HIV con attività idrolizzante delle LTR virali. / Generation of HIV Integrase molecular chimeras targeting viral LTRs as a substrate for hydrolisis.Muthusamy, Regina <1973> 07 April 2014 (has links)
La Sindrome da Immunodeficienza Acquisita (AIDS o SIDA) causata da HIV-1 (Virus dell'Immunodeficienza umana) è caratterizzata dalla graduale compromissione del sistema immunitario del soggetto colpito. Le attuali terapie farmacologiche, purtroppo, non riescono a eliminare l'infezione a causa della comparsa di continui ceppi resistenti ai farmaci, e inoltre questi trattamenti non sono in grado di eliminare i reservoir virali latenti e permettere l'eradicazione definitiva del virus dall’organismo.
E' in questo ambito che si colloca il progetto a cui ho lavorato principalmente in questi anni, cioè la creazione di una strategia per eradicare il provirus di HIV integrato nel genoma della cellula ospite.
L'Integrasi di HIV-1 è un enzima che media l'integrazione del cDNA virale nel genoma della cellula ospite. La nostra idea è stata, quindi, quella di associare all'attività di legame dell'IN stessa, un'attività catalitica. A tal fine abbiamo creato una proteina chimerica costituita da un dominio DNA-binding, dato dall'Integrasi, e da un dominio con attività nucleasica fornito dall'enzima FokI.
La chimera ottenuta è stata sottoposta a mutagenesi random mediante UV, ed è stata oggetto di selezione in vivo, al fine di ottenere una chimera capace di riconoscere, specificamente le LTR di HIV-1, e idrolizzare i siti di inserzione.
Questo lavoro porterà a definire pertanto se l'IN di HIV può essere riprogrammata a catalizzare una nuova funzione mediante la sostituzione dell'attività del proprio dominio catalitico con quello di FokI. / The Acquired Immune Deficiency Syndrome (AIDS) caused by HIV-1 (Human Immunodeficiency Virus) is characterized by progressive impairment of the immune system and the onset of serious disease.
At the moment the AIDS is treated with drugs, in particular the advent of HAART, based on a drug combination therapy, can strongly suppress viral replication and prevent progression of AIDS. But this treatment does not eradicate the HIV reservoir from the host.
For this reason current efforts to improve therapy and prevention are oriented at developing a series of alternative approaches for vaccine development, improvement of HAART and eradication of the virus from the cell.
The aim of our project is to develop a new strategy to eradicate the HIV provirus, for this purpose we created several chimeras between the Integrase of HIV-1 and the catalytic domain of the enzyme FokI that would recognize the LTR ends of the HIV genome and cleave them.
Chimeras were subjected to random UV mutagenesis and in vivo selection to further improve their activity.
This work will define if the Integrase of HIV can be reprogrammed to catalyze a new function by replacing the activity of its catalytic domain with that of FokI.
|
Page generated in 0.2673 seconds